BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 25535351)

  • 1. Only three driver gene mutations are required for the development of lung and colorectal cancers.
    Tomasetti C; Marchionni L; Nowak MA; Parmigiani G; Vogelstein B
    Proc Natl Acad Sci U S A; 2015 Jan; 112(1):118-23. PubMed ID: 25535351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population risk and physiological rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States.
    Herrero-Jimenez P; Tomita-Mitchell A; Furth EE; Morgenthaler S; Thilly WG
    Mutat Res; 2000 Jan; 447(1):73-116. PubMed ID: 10686307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations.
    Rozhok AI; DeGregori J
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):8914-21. PubMed ID: 26195756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
    Li H; Pan Y; Li Y; Li C; Wang R; Hu H; Zhang Y; Ye T; Wang L; Shen L; Sun Y; Chen H
    Lung Cancer; 2013 Jan; 79(1):8-13. PubMed ID: 23098378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting the tumorigenesis timeline with a data-driven generative model.
    Lahouel K; Younes L; Danilova L; Giardiello FM; Hruban RH; Groopman J; Kinzler KW; Vogelstein B; Geman D; Tomasetti C
    Proc Natl Acad Sci U S A; 2020 Jan; 117(2):857-864. PubMed ID: 31882448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes.
    Porta M; Crous-Bou M; Wark PA; Vineis P; Real FX; Malats N; Kampman E
    Mutat Res; 2009; 682(2-3):83-93. PubMed ID: 19651236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies.
    Maus MK; Grimminger PP; Mack PC; Astrow SH; Stephens C; Zeger G; Hsiang J; Brabender J; Friedrich M; Alakus H; Hölscher AH; Lara P; Danenberg KD; Lenz HJ; Gandara DR
    Lung Cancer; 2014 Feb; 83(2):163-7. PubMed ID: 24331409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of colorectal cancer.
    Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
    Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndrome.
    Hemminger JA; Pearlman R; Haraldsdottir S; Knight D; Jonasson JG; Pritchard CC; Hampel H; Frankel WL
    Hum Pathol; 2018 Aug; 78():125-130. PubMed ID: 29723603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel.
    Takamochi K; Takahashi F; Suehara Y; Sato E; Kohsaka S; Hayashi T; Kitano S; Uneno T; Kojima S; Takeuchi K; Mano H; Suzuki K
    Lung Cancer; 2017 Aug; 110():26-31. PubMed ID: 28676214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].
    Zhang HP; Fu L; Chen PQ; Ye YB; Ji TH; Zheng LM
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):757-61. PubMed ID: 21215167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology in colorectal cancer.
    Benito M; Díaz-Rubio E
    Clin Transl Oncol; 2006 Jun; 8(6):391-8. PubMed ID: 16790391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the number of genetic mutations (hits) required for carcinogenesis based on the distribution of somatic mutations.
    Anandakrishnan R; Varghese RT; Kinney NA; Garner HR
    PLoS Comput Biol; 2019 Mar; 15(3):e1006881. PubMed ID: 30845172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative screening of K-ras mutations in colorectal cancer and lung cancer patients using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing.
    Zhang H; Zheng X; Ji T; Fu L; Bai D; Liao Y; Zhang H; Ding Y; Zheng L
    Cell Biochem Biophys; 2012 Apr; 62(3):415-20. PubMed ID: 22048888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
    JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The putative tumor suppressor gene EphA3 fails to demonstrate a crucial role in murine lung tumorigenesis or morphogenesis.
    Lahtela J; Pradhan B; Närhi K; Hemmes A; Särkioja M; Kovanen PE; Brown A; Verschuren EW
    Dis Model Mech; 2015 Apr; 8(4):393-401. PubMed ID: 25713296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer.
    Fang H; Barbour JA; Poulos RC; Katainen R; Aaltonen LA; Wong JWH
    PLoS Genet; 2020 Feb; 16(2):e1008572. PubMed ID: 32012149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the P53 tumour suppressor gene in primary lung cancer in Japan.
    Kondo K; Umemoto A; Akimoto S; Uyama T; Hayashi K; Ohnishi Y; Monden Y
    Biochem Biophys Res Commun; 1992 Mar; 183(3):1139-46. PubMed ID: 1348931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.